benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide has been researched along with Angioblastic Meningioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartal, A; Razon, N; Roth, E; Silman, I; Soreq, H | 1 |
1 other study(ies) available for benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and Angioblastic Meningioma
| Article | Year |
|---|---|
Characterization of activities and forms of cholinesterases in human primary brain tumors.
Topics: Acetylcholinesterase; Adolescent; Adult; Aged; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Brain Neoplasms; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Female; Glioma; Humans; Male; Meningioma; Middle Aged; Molecular Conformation; Tetraisopropylpyrophosphamide | 1984 |